<code id='5618871ED8'></code><style id='5618871ED8'></style>
    • <acronym id='5618871ED8'></acronym>
      <center id='5618871ED8'><center id='5618871ED8'><tfoot id='5618871ED8'></tfoot></center><abbr id='5618871ED8'><dir id='5618871ED8'><tfoot id='5618871ED8'></tfoot><noframes id='5618871ED8'>

    • <optgroup id='5618871ED8'><strike id='5618871ED8'><sup id='5618871ED8'></sup></strike><code id='5618871ED8'></code></optgroup>
        1. <b id='5618871ED8'><label id='5618871ED8'><select id='5618871ED8'><dt id='5618871ED8'><span id='5618871ED8'></span></dt></select></label></b><u id='5618871ED8'></u>
          <i id='5618871ED8'><strike id='5618871ED8'><tt id='5618871ED8'><pre id='5618871ED8'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:5116
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          NEJM study link tiny plastics in blood vessels to heart problems
          NEJM study link tiny plastics in blood vessels to heart problems

          DESIREEMARTIN/AFPviaGettyImagesMicroandnanoplastics,tinypiecesofplasticscatteredthroughouttheenviron

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

          AmandaAndrade-Rhoades/APU.S.regulatorsapprovedalabelexpansionforNovoNordisk’sobesitydrugWegovytotout